Effects of an immunosuppressive therapy on the efficacy of immune checkpoint inhibition in metastatic melanoma – An analysis of the prospective skin cancer registry ADOREGCorinna Kochanek, Ralf Gutzmer, Friedegund Meier et al.|European Journal of Cancer|2023Cited by 7
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Schadendorf, Dirk Debus et al.|Cancers|2026Cited by 0